Edition:
India

Aurinia Pharmaceuticals Reports Qtrly Loss Per Share ‍of $0.04​


Friday, 16 Mar 2018 

March 15 (Reuters) - Aurinia Pharmaceuticals Inc ::AURINIA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS.AURINIA PHARMACEUTICALS INC QTRLY LOSS PER SHARE ‍$0.04​.AURINIA PHARMACEUTICALS INC - ‍TRIALS IN FSGS AND DRY EYE TO BEGIN IN Q2 2018​. 

Company Quote

6.06
-0.11 -1.78%
20 Sep 2019